Yahoo Web Search

  1. EVP, Chief Strategy Officer of Abbvie Inc (30-Year Financial, Insider Trades) Henry O Gosebruch (insider trades) bought 30,000 shares of ABBV on 07/29/2019 at an average price ...

  2. AbbVie (NYSE:ABBV) Shareholders Have Enjoyed A 29% Share Price Gain

    Simply Wall St. via Yahoo FinanceJul 31 10:10 AM

    AbbVie Inc. (NYSE:ABBV) shareholders might be concerned after seeing the share price drop 14% in the last quarter. On the bright side the share price is up over the last half decade ...

  3. ABBV Options Traders React to Piper Jaffray Upgrade

    Schaeffer's Investment Research via Yahoo FinanceAug 20 17:48 PM

    Abbvie Inc (NYSE:ABBV) is trying to recover from last week's two-year low, getting a boost today from an upgrade to "overweight" from "neutral" at Piper Jaffray, which also set ...

  4. Allergan Plc, which is being bought by AbbVie Inc for $63 billion, beat quarterly profit estimates and raised its 2019 revenue forecast on Tuesday, helped by demand for its dry ...

  5. Top Research Reports: Chevron, AbbVie, Phillips 66 & More

    Zacks via Yahoo FinanceAug 06 15:53 PM

    ... Report Chevron Corporation (CVX) : Free Stock Analysis Report ConocoPhillips (COP) : Free Stock Analysis Report AbbVie Inc. (ABBV) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research

  6. The European Commission granted approval to AbbVie's ABBV chronic hepatitis C drug Maviret and Sanofi's SNY eczema medicine Dupixent for expanded patients groups. Pfizer PFE, Roche RHHBY ...

  7. Despite the slight dip, TD Ameritrade clients were overall net buyers in July, although they reduced their exposure to equity markets in favor of less-risky options like fixed-income products ...

  8. The strong earnings performance of pharma companies continued this week with AbbVie ABBV, Merck MRK and Lilly LLY delivering better-than expected results and also boosting their guidance ...

  9. Investor Movement Index Summary: July 2019

    Benzinga via Yahoo FinanceAug 05 18:22 PM

    The Investor Movement Index, or the IMX, is a proprietary, behavior-based index created by TD Ameritrade designed to indicate the sentiment of retail investors. Exposure to equity markets was ...

  10. ImmunoGen, Inc. IMGN reported loss of 29 cents per share for the second quarter of 2019, narrower than the Zacks Consensus Estimate of a loss of 32 cents and the year-ago loss of 31 cents ...

  1. Ads
    related to AbbVie Inc